m-PEG4-Ms

97%

Reagent Code: #106263
fingerprint
CAS Number 130955-37-2

science Other reagents with same CAS 130955-37-2

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 286.34 g/mol
Formula C₁₀H₂₂O₇S
badge Registry Numbers
MDL Number MFCD30723269
inventory_2 Storage & Handling
Storage 2-8°C, dry, sealed

description Product Description

Used extensively in bioconjugation and drug delivery systems, it serves as a linker to attach therapeutic molecules or targeting ligands to nanoparticles or proteins. Its methanesulfonate group allows for efficient coupling reactions, while the PEG spacer enhances solubility and reduces immunogenicity. Commonly applied in the development of antibody-drug conjugates (ADCs) and prodrugs, it improves pharmacokinetics and bioavailability. Additionally, it is utilized in the modification of peptides and proteins to prolong their circulation time in vivo. Its versatility makes it valuable in creating innovative therapeutic agents and biomaterials.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 250mg
10-20 days ฿9,000.00
inventory 100mg
10-20 days ฿5,850.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
m-PEG4-Ms
No image available

Used extensively in bioconjugation and drug delivery systems, it serves as a linker to attach therapeutic molecules or targeting ligands to nanoparticles or proteins. Its methanesulfonate group allows for efficient coupling reactions, while the PEG spacer enhances solubility and reduces immunogenicity. Commonly applied in the development of antibody-drug conjugates (ADCs) and prodrugs, it improves pharmacokinetics and bioavailability. Additionally, it is utilized in the modification of peptides and prote

Used extensively in bioconjugation and drug delivery systems, it serves as a linker to attach therapeutic molecules or targeting ligands to nanoparticles or proteins. Its methanesulfonate group allows for efficient coupling reactions, while the PEG spacer enhances solubility and reduces immunogenicity. Commonly applied in the development of antibody-drug conjugates (ADCs) and prodrugs, it improves pharmacokinetics and bioavailability. Additionally, it is utilized in the modification of peptides and proteins to prolong their circulation time in vivo. Its versatility makes it valuable in creating innovative therapeutic agents and biomaterials.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...